Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) announced that the results from SAkuraStar Study were presented at the...
Hansoh Pharmaceutical Group Company Limited (“Hansoh Pharma”), a leading biopharmaceutical company in China,...
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) has announced the submission of a New Drug Application...
Invicro , a member of the Konica Minolta Group and a leading provider of biomarkers for imaging, core lab services and s...
THC Global Group Limited (THC Global or the Company) has announced that its Southport Facility was opened by the Federal...
AstraZeneca has announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for the deve...
Cantargia AB and BioWa Inc. have signed an extension of the license agreement around the BioWa proprietary POTELLIGENTTe...
Voronoi, drug discovery and development biotech company in Korea has announced that it has, after an extensive evaluatio...
Innovent Biologics, Inc., a world-class biopharmaceutical company that develops and commercializes high-quality medicine...
The U.S. Food and Drug Administration, on 19 August 2019, approved Xenleta (lefamulin) to treat adults with community-ac...
Pretomanid, a novel compound developed by the non-profit organization TB Alliance, was approved by the U.S. Food & D...
Genentech, a Roche’s subsidiary announced that the US Food and Drug Administration (FDA) has approved Rozlytrek&tr...
Certara®, the global model-informed drug development and decision support leader, on 30 July 2019, announced the lau...
Bayer AG and BlueRock Therapeutics hasannounced an agreement under which Bayer will fully acquire BlueRock Therapeutics,...
Sun Pharmaceutical Industries Ltd. has announced that one of its wholly owned subsidiaries has filed an application for ...
Pfizer Inc. announced the successful completion of its acquisition of Array BioPharma Inc., advancing breakthrough...
3SBio Inc., a leading biopharmaceutical company in the People's Republic of China (PRC) has announced that an applicatio...
AstraZeneca has announced that data from two Phase III trials evaluating the efficacy and safety of roxadustat in China....